CLINICAL_TRIALS
trial_result
· 2017-09-08
Clinical Trial Update: A Study of AGN-195263 for the Treatment of Meibomian Gland Dysfunction [Phase 2]
Summary
Phase 2 trial of AGN-195263 for Meibomian Gland Dysfunction has completed, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Meibomian Gland Dysfunction | Phase 2 | Status: COMPLETED | Results posted: 2017-09-08